Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2010 Jan-Feb;12(1):85-8.
doi: 10.1007/s11307-009-0232-1. Epub 2009 May 9.

PET/CT in the evaluation of inflammatory bowel disease: studies in patients before and after treatment

Affiliations

PET/CT in the evaluation of inflammatory bowel disease: studies in patients before and after treatment

Bret J Spier et al. Mol Imaging Biol. 2010 Jan-Feb.

Abstract

Purpose: The purpose of this study was to evaluate the appropriate 2-deoxy-2-[(18)F]fluoro-D-glucose-positron emission tomography (FDG-PET) determination in patients with inflammatory bowel disease (IBD) before and after clinical improvement to see if this determination correlates with clinical activity.

Procedures: We performed PET-computed tomography (PET/CT) on five patients before and after successful medical therapy in patients with moderately active IBD. Each patient had five bowel segments scored (0-3) for the appropriate FDG-PET determination.

Results: There were five patients [Crohn's disease (CD) = 3, ulcerative colitis = 2] who were studied an average of 437 days (range, 77-807) after initial PET/CT scan. All patients showed significant improvement in physician global assessment scores (p = 0.004) and underwent repeat PET/CT. The total score of all segments was 32 pretreatment and 14 posttreatment (p < 0.01). Of 11 pretreatment active segments, nine (82%) segments either became inactive or displayed decreased activity, while two showed no change (p < 0.001).

Conclusion: Appropriate FDG-PET determination decreases with successful treatment of inflammation in active IBD and correlates with symptom improvement.

PubMed Disclaimer

References

    1. Gastroenterology. 1976 Mar;70(3):439-44 - PubMed
    1. Lancet. 1999 Sep 4;354(9181):836-7 - PubMed
    1. Am J Gastroenterol. 2002 Aug;97(8):1978-85 - PubMed
    1. Gut. 1991 Sep;32(9):1071-5 - PubMed
    1. Inflamm Bowel Dis. 2005 Aug;11(8):733-8 - PubMed

Publication types

Substances